Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action

WJ Guan, XY Zheng, KF Chung, NS Zhong - The Lancet, 2016 - thelancet.com
In China, where air pollution has become a major threat to public health, public awareness
of the detrimental effects of air pollution on respiratory health is increasing—particularly in …

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003

NS Zhong, BJ Zheng, YM Li, LLM Poon, ZH Xie… - The Lancet, 2003 - thelancet.com
NS Zhong and BJ Zheng contributed equally to this article. Y Guan and NS Zhong are
coprincipal investigators who supervised the virological and clinical components of the study. BJ …

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

…, JZ Yuan, BT Yuan, HP Qian, RC Zhi, NS Zhong - The Lancet, 2008 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is characterised by airflow
limitation, and has many components including mucus hypersecretion, oxidative stress, and …

Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study

…, SJ Fan, ZB Zhang, DM Zhang, NS Zhong - Emerging microbes & …, 2021 - Taylor & Francis
The effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant, which has
been associated with greater transmissibility and virulence, remains unclear. We conducted …

Overview on SARS in Asia and the world

WK Lam, NS Zhong, WC Tan - Respirology, 2003 - Wiley Online Library
Severe Acute Respiratory Syndrome (SARS) is the first major novel infectious disease to hit
the international community in the 21st century. It originated in southern China in November …

[HTML][HTML] Clinical findings in 111 cases of influenza A (H7N9) virus infection

…, BM Hou, ZX Feng, JF Sheng, NS Zhong… - … England Journal of …, 2013 - Mass Medical Soc
Background During the spring of 2013, a novel avian-origin influenza A (H7N9) virus emerged
and spread among humans in China. Data were lacking on the clinical characteristics of …

SARS: pharmacotherapy

K Tsang, NS Zhong - Respirology, 2003 - Wiley Online Library
… ArticleSARS: pharmacotherapyK Tsang and NS Zhong … 20 Zheng ZG & Zhong NS. The
use of corticosteroid in man… 21 Zhong NS & Zeng GQ. Our strategies for fighting severe …

Asthma control in the Asia-Pacific region: the asthma insights and reality in Asia-Pacific study

…, JB Soriano, PL Trung, NS Zhong… - Journal of allergy and …, 2003 - Elsevier
Background: Few data on asthma management are available for the Asia-Pacific region.
Objective: This study examined asthma symptoms, health care use, and management in the …

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

…, M Sardina, Y Gao, BS Wang, NS Zhong - The Lancet …, 2014 - thelancet.com
Background Increased oxidative stress and inflammation has a role in the pathogenesis of
chronic obstructive pulmonary disease (COPD). Drugs with antioxidant and anti-inflammatory …

Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates

…, XW Kong, QY Zhu, Q Zhong, M Xu, NS Zhong… - ACS …, 2021 - ACS Publications
The coronavirus disease pandemic of 2019 (COVID-19) caused by the novel SARS-CoV-2
coronavirus resulted in economic losses and threatened human health worldwide. The …